TP53 and hepatocellular carcinoma: With regard to survival, we found that HCC patients with high p53 expression, high β-catenin expression, high SOX9 expression and low SOX2 expression had significantly worse survival time than those with low p53, β-catenin, and SOX9 and SOX2 expression by Kaplan–Meier analysis.